Report disponibiliAvailable reports
NTLA Intellia Therapeutics n/dn/a
NASDAQ Biotech / gene editingBiotech / gene editing Aggiornato: n/dn/aUpdated: n/dn/a
Scheda operativaTrading sheet
DirezioneDirectionn/dn/a
TargetTargetn/dn/a
Resistenza (R1)Resistance (R1)n/dn/a
Supporto (S1)Support (S1)n/dn/a
ReportReport

Intellia Therapeutics sviluppa terapie basate sull’editing genetico CRISPR.

Intellia Therapeutics develops therapies based on CRISPR gene editing.

La sintesi quotidiana dell’analisi appare qui dopo la prima esecuzione della pipeline.

The daily synthesis of the analysis appears here after the first pipeline run.

Profilo dell’azienda a parte, questa pagina non riporta ancora dati di mercato: valori operativi, previsioni e accuratezza compaiono quando la pipeline di analisi viene eseguita.Company profile aside, this page does not yet report market data: trading values, forecasts and accuracy appear once the analysis pipeline runs.